
  
    
      
        
        Richard_NNP Smith_NNP 's_POS key_JJ suggestion_NN [_NN 1_CD ]_NN is_VBZ that_IN medical_JJ journals_NNS “ should_MD stop_VB publishing_VBG
        trials_NNS” and_CC concentrate_VB on_IN “ critically_RB evaluating_VBG them_PRP ._.” This_DT bold_JJ and_CC radical_JJ suggestion_NN
        deserves_VBZ wide_JJ debate_NN ._. It_PRP 's_VBZ obvious_JJ that_IN many_JJ medical_JJ journals_NNS are_VBP losing_VBG relevance_NN as_IN
        vehicles_NNS for_IN scientific_JJ information_NN ,_, but_CC it_PRP 's_VBZ unclear_JJ what_WP will_MD save_VB them_PRP ._. Even_RB as_IN journals_NNS
        strive_VBP to_TO better_JJR enforce_VB their_PRP$ conflicts-of-interest_JJ disclosure_NN rules_NNS ,_, drug_NN companies_NNS will_MD
        strive_VBP to_TO find_VB or_CC create_VB other_JJ publication_NN outlets_NNS that_WDT can_MD communicate_VB to_TO physicians_NNS
        precisely_RB what_WP advertisers_NNS wish_VBP to_TO communicate_VB ._. In_IN sum_NN ,_, an_DT unanticipated_JJ effect_NN of_IN purging_VBG
        clinical_JJ trial_NN reports_NNS from_IN medical_JJ journals_NNS might_MD be_VB an_DT even_RB larger_JJR proliferation_NN of_IN frank_JJ
        advertising_NN outlets_NNS and_CC messages_NNS that_WDT might_MD more_RBR effectively_RB catch_VB doctors_NNS '_POS attentions_NNS ._.
      
    
  
